NHI Q4 EPS $0.74 vs $0.04 YoY; issues 2024 NAREIT FFO guidance $4.31-$4.37

NATIONAL HEALTH INVESTORS INC

2023-FY EPS reported $3.13 revenue$319,835,000

Q4 diluted EPS $0.74 (vs $0.04); full-year EPS $3.13 (vs $1.48).
Q4 NAREIT FFO $1.09/diluted share (vs $0.74); FY FFO $4.39 (vs $3.55).
2024 guidance: NAREIT FFO $4.31-$4.37; Normalized FAD $191.3M-$194.1M.
Board approved $160M share repurchase plan for one year.
Net debt-to-adjusted EBITDA at 4.4x; liquidity includes $500M ATM program.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

NATIONAL HEALTH INVESTORS INC reported the three and twelve months ended December 31, 2023 results: net income Net income attributable to common stockholders per diluted common share for the three months ended December 31, 2023 was, EPS Net income attributable to common stockholders per diluted common share for the three months ended December 31, 2023 was. Guidance initiated.

Period: the three and twelve months ended December 31, 2023
Net income: Net income attributable to common stockholders per diluted common share for the three months ended December 31, 2023 was
EPS: Net income attributable to common stockholders per diluted common share for the three months ended December 31, 2023 was
Guidance: initiated
Result: reported results

Exact text from the filing

NHI Announces Fourth Quarter 2023 Results MURFREESBORO, Tenn. – (February 20, 2024) National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and twelve months ended December 31, 2023.

View on SEC.gov

Browse all earnings releases →

NATIONAL HEALTH INVESTORS INC filing history →

Source: SEC EDGAR

accession 0000877860-24-000012

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.